Fas, a cell surface receptor, can induce apoptosis after cross-linking
with its ligand, Fewer than 3% of human thymocytes strongly express F
as. We report that Fas antigen expression can be upregulated by two si
gnaling pathways in vitro, one mediated by anti-CDB and the other by i
nterleukin-7 + interferon-gamma. The two signaling pathways differed i
n several respects. (1) Fas expression increased in all thymic subsets
after cytokine activation, but only in the CD4 lineage after anti-CDB
activation. (2) Fas upregulation was inhibited by cyclosporin A (a ca
lcineurin inhibitor) in anti-CD3-activated but not in cytokine-activat
ed thymocytes, (3) Cycloheximide (a metabolic inhibitor) inhibited Fas
upregulation in cytokine-activated thymocytes but not in anti-CD3-act
ivated thymocytes, (4) Cytokine-activated thymocytes were more suscept
ible than anti-CD3-activated thymocytes to Fas-induced apoptosis, a di
fference mainly accounted for by CD4(+) cells. The nature of the stimu
lus might thus influence the susceptibility of human thymocytes to Fas
-induced apoptosis. (C) 1998 by The American Society of Hematology.